Aptose Biosciences Inc.

NASDAQ: APTO · Real-Time Price · USD
1.71
0.00 (0.00%)
At close: Apr 01, 2025, 3:59 PM

Aptose Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-25.43M -51.21M -41.82M -65.35M
Depreciation & Amortization
404K 466K 528K 622K
Stock-Based Compensation
1.06M 3.65M 5.21M 12.95M
Other Working Capital
-6.24M 2.45M -126.67K 1.99M
Other Non-Cash Items
-986K 48.9K -551K 6.96M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-11.03M 2.45M 4.32M 1.52M
Operating Cash Flow
-35.98M -44.59M -32.32M -43.3M
Capital Expenditures
-5K -29K -24K -212K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a -35M
Sales Maturities Of Investments
n/a 9.99M 28.9M n/a
Other Investing Acitivies
23K n/a 1.19M n/a
Investing Cash Flow
18K 9.96M 30.07M -35.21M
Debt Repayment
10M n/a n/a n/a
Common Stock Repurchased
26K n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
28K 29K 15K 190K
Financial Cash Flow
33.41M 6.91M 116K 226K
Net Cash Flow
-2.54M -27.72M -2.14M -78.28M
Free Cash Flow
-35.98M -44.62M -32.35M -43.52M